DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,048 filers reported holding DANAHER CORPORATION in Q3 2016. The put-call ratio across all filers is 0.17 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $528,183 | +0.1% | 2,114 | 0.0% | 0.06% | -3.1% |
Q1 2024 | $527,908 | +7.9% | 2,114 | 0.0% | 0.06% | -4.4% |
Q4 2023 | $489,053 | -6.8% | 2,114 | 0.0% | 0.07% | -16.0% |
Q3 2023 | $524,483 | +3.4% | 2,114 | 0.0% | 0.08% | +20.9% |
Q2 2023 | $507,360 | -8.4% | 2,114 | -3.8% | 0.07% | -9.5% |
Q1 2023 | $553,984 | -10.7% | 2,198 | -5.9% | 0.07% | -11.9% |
Q4 2022 | $620,287 | +10.0% | 2,337 | +7.0% | 0.08% | +3.7% |
Q3 2022 | $564,000 | +1.8% | 2,184 | 0.0% | 0.08% | +8.0% |
Q2 2022 | $554,000 | -13.6% | 2,184 | 0.0% | 0.08% | -1.3% |
Q1 2022 | $641,000 | -10.8% | 2,184 | 0.0% | 0.08% | -3.8% |
Q4 2021 | $719,000 | +8.1% | 2,184 | 0.0% | 0.08% | +19.7% |
Q3 2021 | $665,000 | +13.5% | 2,184 | 0.0% | 0.07% | +1.5% |
Q2 2021 | $586,000 | +19.1% | 2,184 | 0.0% | 0.06% | +18.2% |
Q1 2021 | $492,000 | +1.4% | 2,184 | 0.0% | 0.06% | -22.5% |
Q4 2020 | $485,000 | +3.2% | 2,184 | 0.0% | 0.07% | +16.4% |
Q3 2020 | $470,000 | +17.5% | 2,184 | 0.0% | 0.06% | +154.2% |
Q2 2020 | $400,000 | +26.6% | 2,184 | -4.4% | 0.02% | -50.0% |
Q1 2020 | $316,000 | -13.7% | 2,284 | -4.2% | 0.05% | -2.0% |
Q4 2019 | $366,000 | -3.7% | 2,384 | -9.5% | 0.05% | -2.0% |
Q3 2019 | $380,000 | -12.8% | 2,634 | -13.6% | 0.05% | -19.4% |
Q2 2019 | $436,000 | +10.1% | 3,050 | +1.7% | 0.06% | +6.9% |
Q1 2019 | $396,000 | +21.5% | 3,000 | 0.0% | 0.06% | +18.4% |
Q4 2018 | $326,000 | 0.0% | 3,000 | 0.0% | 0.05% | -2.0% |
Q3 2018 | $326,000 | +10.9% | 3,000 | 0.0% | 0.05% | +8.7% |
Q2 2018 | $294,000 | 0.0% | 3,000 | 0.0% | 0.05% | -8.0% |
Q1 2018 | $294,000 | +5.8% | 3,000 | 0.0% | 0.05% | +31.6% |
Q4 2017 | $278,000 | +5.7% | 3,000 | -2.3% | 0.04% | +2.7% |
Q3 2017 | $263,000 | +4.0% | 3,071 | +2.4% | 0.04% | 0.0% |
Q2 2017 | $253,000 | -1.6% | 3,000 | 0.0% | 0.04% | -7.5% |
Q1 2017 | $257,000 | +9.8% | 3,000 | 0.0% | 0.04% | 0.0% |
Q4 2016 | $234,000 | -0.4% | 3,000 | 0.0% | 0.04% | -4.8% |
Q3 2016 | $235,000 | – | 3,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |